Many thanks to the Ohio State Alumni Association Board of Directors for touring the #PIIO . Special thanks to Dr. Timothy Gauntner (@Zihai Lab) who discussed the important work being done to better understand the molecular basis of sex differences in #immune response to #cancer .

🚨JOB ALERT🚨 #PIIO #ImmuneMonitoring & Discovery Platform (go.osu.edu/imdp) seeks a #FlowCytometry Scientist w/ at least 5-10 yrs experience w/ flow instruments (Cytek Aurora, BD FACS Melody, etc.) & proficiency in FlowJo & Omiq. For more info👇
go.osu.edu/imdpflow

Meet Dr. Mark Rubinstein Pelotonia Institute for Immuno-Oncology, a brilliant mind whose foundational work (PNAS 2006, PMID: 16757567; Blood 2008, PMID: 18689546; Lancet Oncol 2018, PMID: 29628312; JI 2022, PMID: 35228263) led to U.S. FDA approval of ImmunityBio, Inc. #ANKTIVA , a FIC IL-15R agonist for NMIBC.

The #PIIO loved spending some time with Rocky from Buckeye Paws on Tuesday! 🐾

Greetings, #PIIO ! We're selling Team Buckeye Raffle Tickets to raise funds for Pelotonia 2024. 100% of proceeds are dedicated to #cancer research at the
The James
. Please DM for more info. Please Retweet! cancer.osu.edu/for-donors-and…

Congratulations to the inaugural cohort of the Master of Science in Immunology and Microbial Pathogenesis on your upcoming graduation! We can’t wait to see you continue on your journey in science. #MIIproud

🎉Kudos to Michael Ruesch, MSTP Student in the lab of Dr. Aharon Freud. Michael received a Pelotonia Graduate Scholar award for his project titled “Paradoxical effects of #IL15 Signaling in #NK maturation and KIR acquisition.”

👏Congrats to Dr. Jay Mandula (postdoc in the Zihai Li, MD, PhD Lab), who received a Pelotonia PostDoctoral Scholar award for his project titled “Leveraging #immunogenic cell death to reprogram the #immunosuppressive_tumor_microenvironment and restore #antitumor_immunity in #BladderCancer ”

“Leveraging the gut microbiome to enhance the activity of IO drugs in cancer patients” with Saman Maleki, PhD for our #PIIO Special Seminar today. Great insight into the role of bugs on therapeutic response!

Excited to hear Jordan Krull, 2023 Pelotonia Postdoctoral Scholar, present on how #DeepLearning is revolutionizing digital pathology! His insights on extracting crucial numerical features from pathology slides are reshaping medical diagnostics. Zihai Li, MD, PhD Qin Ma BMBL #IOIG #PIIO

Inspiring day at the 2024 Pelotonia Research Scholars Symposium! Incredible to see the groundbreaking work being done by current scholars as well as the amazing success stories of past scholars. Together, we are #Creating_A_Cancer_Free_World . 🧬🔬🚴‍♀️🎓

.The James is one of the few cancer centers in the nation offering #TIL therapy for cancer patients with advanced solid tumors, as we lead the charge towards a #cancer free world. #PIIO member Joal Beane explains in this quick video 👀👀

TOMORROW‼️‼️ Make sure to join us at the Pelotonia Scholars Symposium, featuring amazing research from previous and current Pelotonia Scholars.

📝New publication from Kai He & colleagues on Lifileucel, an Autologous #TIL Monotherapy, in Patients with Advanced #NSCLC Resistant to #ICIs Cancer Discovery

doi.org/10.1158/2159-8…

Unveiling the hidden layers of sex bias in immuno-oncology! Discover how biological sex influences cancer outcomes & treatment responses by diving into perspectives by Zihai Li, MD, PhD and Justin Lathia, PhD 🧠🕺🏽 labs in this Nature Reviews Cancer article
#SexBias #ImmunoOncology
go.osu.edu/Cps8

Check out recent PNASNews pub by Yaa Amankwah (@ysarfowah), Dr. Andrea Kravats (@KravatsLab), & others where they uncover unique mechanisms in protein folding of ER chaperones, such as Grp94. Dr. Amankwah recently joined the #PIIO in the lab of Zihai Li, MD, PhD!
go.osu.edu/Cpsc

🔬 Exciting opportunity alert! Join us at the Pelotonia Scientific Symposium featuring groundbreaking research from Pelotonia-funded scholars. Learn about the impact of research funding and support their work. Register now for this exciting event!
go.osu.edu/CpjD

Very happy to be representing Qin Ma BMBL lab and Pelotonia Institute for Immuno-Oncology at AACR this year. Very excited to see some of the new computational work on TME and immune-oncology. Stop by my poster 4879 Monday morning and see some of our ongoing work with Gunderlab studying TLSs in ST data.

#FollowFriday Dr. Zihai Li is the Founding Director of the Pelotonia Institute for Immuno-Oncology at The James. He's a great leader, wonderful friend and colleague and has done some outstanding science in the areas of TGFβ, the tumor microenvironment and the impact of sex…

Join us today for #PIIO research in progress by Jacob Kaufman, entitled 'Differentiation phenotypes induce distinct immunotherapy resistance mechanisms in STK11-deficient lung cancer.’